Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Gazouli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Vaccines|September 27, 2025
Individualized mRNA Vaccines in Melanoma-Where Do We Stand?Ioanna Gazouli, Dimitrios Bafaloukos, Christos Koutserimpas, et al.
Vaccines|March 30, 2023
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future ProspectsDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|June 29, 2010
A rare variation of the axillary artery combined contralaterally with an unusual high origin of a superficial ulnar artery: description, review of the literature and embryological analysisEleni Panagouli, Athanasios Tsaraklis, Ioanna Gazouli, et al.
Cureus|January 15, 2024
Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma PatientDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Immunotherapy|September 11, 2024
Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicityDimitrios Bafaloukos, Ioanna Gazouli, Aikaterini Bousmpoukea, et al.
Cancer Treatment and Research Communications|August 17, 2021
Is there a role for Gallium-67 SPECT in distinguishing progression and pseudoprogresion in oncologic patients receiving immunotherapy?Davide Mauri, Spyridon Tsiouris, Stefania Gkoura, et al.
Case Reports in Oncology|February 29, 2020
Acquired Hemophilia in an Elderly Patient with Carcinoma of the Ampulla of VaterLeonidas Mavroeidis, Amalia Vassou, George Zarkavelis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Advanced germ cell tumors and chemotherapy in G6PD deficient patients: Yes to chemotherapy but no to rasburicase and some premedicationsIoanna Gazouli, Dimitris Baltogiannis, Panagiotis Ntellas, et al.
Contemporary Oncology (Poznan, Poland)|June 10, 2020
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literatureGeorge Zarkavelis, Davide Mauri, Fotini Karassa, et al.
Frontiers in Endocrinology|December 28, 2020
Chemotherapy Associated Ovarian FailureDavide Mauri, Ioanna Gazouli, Georgios Zarkavelis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vaccines|September 27, 2025
Individualized mRNA Vaccines in Melanoma-Where Do We Stand?Ioanna Gazouli, Dimitrios Bafaloukos, Christos Koutserimpas, et al.
Vaccines|March 30, 2023
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future ProspectsDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|June 29, 2010
A rare variation of the axillary artery combined contralaterally with an unusual high origin of a superficial ulnar artery: description, review of the literature and embryological analysisEleni Panagouli, Athanasios Tsaraklis, Ioanna Gazouli, et al.
Cureus|January 15, 2024
Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma PatientDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Immunotherapy|September 11, 2024
Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicityDimitrios Bafaloukos, Ioanna Gazouli, Aikaterini Bousmpoukea, et al.
Cancer Treatment and Research Communications|August 17, 2021
Is there a role for Gallium-67 SPECT in distinguishing progression and pseudoprogresion in oncologic patients receiving immunotherapy?Davide Mauri, Spyridon Tsiouris, Stefania Gkoura, et al.
Case Reports in Oncology|February 29, 2020
Acquired Hemophilia in an Elderly Patient with Carcinoma of the Ampulla of VaterLeonidas Mavroeidis, Amalia Vassou, George Zarkavelis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Advanced germ cell tumors and chemotherapy in G6PD deficient patients: Yes to chemotherapy but no to rasburicase and some premedicationsIoanna Gazouli, Dimitris Baltogiannis, Panagiotis Ntellas, et al.
Contemporary Oncology (Poznan, Poland)|June 10, 2020
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literatureGeorge Zarkavelis, Davide Mauri, Fotini Karassa, et al.
Frontiers in Endocrinology|December 28, 2020
Chemotherapy Associated Ovarian FailureDavide Mauri, Ioanna Gazouli, Georgios Zarkavelis, et al.
Pageof 2